Editor's Note This study led by researchers at Beth Israel Deaconess Medical Center, Boston, finds that being boosted with either the Janssen (Johnson & Johnson) or Pfizer-BioNTech vaccine was associated with increased humoral and cellular immune responses. Boosting with the Janssen vaccine also was associated with durable antibody and T-cell…

Read More

Editor's Note On Tuesday, August 9, US officials announced they will modify dosing instructions for the Jynneos monkeypox vaccine to stretch the supply, US News & World Report July 10 reports. Currently, there are almost 9,500 known cases in the US, predominantly among gay and bisexual men. According to the…

Read More

Editor's Note  US government researchers found that lab-engineered antibody has protected the majority of participants from the malaria parasite, including those who received a higher dosage of the antibody, US News & World August 4 reports. The antibody can also be given with a standard injection, instead of the typical…

Read More

Editor's Note The Biden administration will begin a COVID-19 booster campaign for revamped vaccines in September, the New York Times July 28 reports. This new booster is predicted to provide more extensive protection against the Omicron subvariants. Federal officials made the decision that individuals over 50 and those over 12…

Read More

Editor's Note On July 23, the World Health Organization (WHO) director-general declared monkeypox a public health emergency of international concern following the agency’s emergency committee inability to reach a consensus, Becker’s Hospital Review July 25 reports. After the no conclusion was drawn in the most recent meeting, WHO Director-General Dr…

Read More

Editor's Note On July 19, Centers for Disease Control and Prevention (CDC) advisers said the 26 to 37 million adults in the US who have yet to get a COVID-19 vaccination should consider the “more traditional” vaccine Novavax, Modern Healthcare July 19 reports. Novavax is the “first so-called protein vaccine”…

Read More

Editor's Note The World Health Organization (WHO) announced on July 12 that it will hold an emergency meeting—the second emergency meeting convened—next week to determine the global health risk of monkeypox, CNBC July 12 reports. The organization decided not to declare monkeypox a global health emergency just last month, noted…

Read More

Editor's Note The US Department of Health and Human Services (HHS) on July 1 announced it ordered an additional 2.5 million doses of the FDA-licensed Bavarian Nordic's JYNNEOS vaccine in response to current or future monkeypox outbreaks and as part of US smallpox preparedness, Healthcare Purchasing News (HPN) July 5…

Read More

Editor's Note The Food and Drug Administration (FDA) authorized COVID-19 vaccines for children as young as 6 months old, which expands eligibility to some 20 million babies, toddlers, and preschoolers, CBS News June 17 reports. After convening on Saturday, June 18, the Centers for Disease Control and Prevention (CDC) also…

Read More

Editor's Note Moderna, Inc announced new clinical data on its “Omicron-containing bivalent” COVID-19 booster candidate and a vaccine candidate targeting the Omicron variant of concern, Healthcare Purchasing News (HPN) June 9 reports. The booster dose of the new mRNA vaccine reportedly had a “superior neutralizing antibody response…against the Omicron variant…

Read More